Lupin forays into OTC segment;eyes Rs 300 crore turnover in 5 years

Softovac's shift to OTC was piloted in West Bengal during which the brand witnessed a growth in sales of over 25 per cent, and post the success, a pan-India rollout was initiated.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news